Conor McClune
@cmcclune.bsky.social
510 followers 930 following 42 posts
Plants, specialized metabolism, synthetic biology, protein evolution, and everything in between. Postdoc at Sattley & Fordyce Labs, Stanford Previously SynBio @ Voigt & Laub Labs, MIT
Posts Media Videos Starter Packs
Pinned
cmcclune.bsky.social
Today in Nature we report a systematic strategy to activate & identify gene sets in plants. We identify 8 new genes from the yew tree's Taxol biosynthetic pathway, enabling us to engineer tobacco with 17- & 20-gene pathways to Taxol precursors baccatin III & deBz-deoxy-Taxol #SingleCell #secmet 🧬🧪🌾
Discovery of FoTO1 and Taxol genes enables biosynthesis of baccatin III - Nature
An approach that combines single-nucleus RNA sequencing and multiplexed perturbation identifies genes that enable the biosynthesis of direct precursors of the anti-cancer drug Taxol, whose curren...
www.nature.com
Reposted by Conor McClune
radinbio.bsky.social
Do you know what happens when you touch a carnivorous sundew plant?
If the touch is strong and large enough, a cytosolic calcium wave will spread from the site of touch throughout the whole plant, but if you only touch one tentacle (see post below), the calcium wave will be local and less intense.
cmcclune.bsky.social
Perhaps in a couple years Claude* will pity the slow, handicapped way we now study metabolites’ in planta roles
cmcclune.bsky.social
Point taken. It’s empowering that we now have easy transient expression, cheap NGS, cheap synthesis, huge databases, computers, electricity, etc now.

Perhaps in a couple years scientists will pity the slow, handicapped way we now study metabolites’ in planta roles
cmcclune.bsky.social
Agree with @chenxinli2.bsky.social - cloning and testing in bentamiana is fast, but gene discovery is still slow and challenging when our initial hypotheses are incorrect (often). guessing we're also running into silent obstacles like localization, scaffolding, cofactors, etc
cmcclune.bsky.social
A truly enabling new approach by @taralowensohn.bsky.social Will Cody and @sattelylab.bsky.social to probe plant genetics at scale.

Single-gene-per-cell delivery coupled to an effective transcriptional selection system

www.biorxiv.org/content/10.1...
Reposted by Conor McClune
Reposted by Conor McClune
plosbiology.org
Elucidating #plant #Biosynthetic pathways: @jjjvanderhooft.bsky.social @marnixmedema.bsky.social &co develop #MEANtools, an unsupervised computational workflow that integrates #MultiOmics data to predict #metabolic pathways by linking transcripts to metabolites @plosbiology.org 🧪 plos.io/4odL94g
Detection of functional clusters (FCs) specific to the phenylalanine (PAL) and p-coumaroyltyramine (THT) pathways. Top left: Network depicting the relationship between transcripts and mass signatures within the PAL FC. Bottom left: Network illustrating the interplay between transcripts and mass signatures within the THT FC. Top right: Heatmap illustrating the expression levels of all transcripts within the PAL and THT FCs. Upper middle right: Heatmap displaying the abundance of all mass signatures present in the PAL and THT FCs. Lower middle right: Correlation matrix highlighting the correlations among transcripts and mass signatures within the PAL FC. Bottom right: Correlation matrix displaying the relationships between transcripts and mass signatures within the THT FC, including Mutual rank and transformed edge weights.
Reposted by Conor McClune
spitewinter.bsky.social
#plants #trees #history #botany #art 🌲

Taxus baccata - English Yew, Common Yew

Folk lore has it that the English used Churchyard Yew longbows - not true. Spanish Yew was straighter and better quality. (Confirmed by an Olympian archer I knew.)

Bows and trees:
www.longbow-archers.com/longbow.html
Reposted by Conor McClune
proflhunter.bsky.social
Scientists, please take a moment to comment on these plans to limit animal testing in drug regulation and biomedical research. Use whatever experience you have to make your comments specific to you. The law requires regulators take these comments into account, so it might help. Mine is attached.
I am a full professor of pediatrics at the University of Chicago, and a world renowned expert in artificial intelligence and molecular biology, particularly AI and drug discovery.  I obtained a Ph.D. in artificial intelligence (computer science) from Yale University in 1989, was a staff scientist at NIH from 1989 to 2000, when I moved to the University of Colorado School of Medicine to become a professor of Pharmacology. I have published more than 200 scientific papers and hold two US patents.  In addition to my faculty position, I am also the chief technology officer of TenZero Biosciences, an early stage drug discovery company.  Not incidental to this letter, I am also a frequent volunteer participant (subject) in clinical trials. 

I have spent my career trying to create artificial intelligence systems that facilitate the discovery of new pharmaceuticals.  In 2003, I won the American Association for Artificial Intelligence's Engelmore Prize for Innovative Applications of AI for my work in AI and molecular biology.  In that talk, I proposed a better version of the "Turing Test" for whether a computer system is actually intelligent would be one getting credit for inventing a new drug.  We are quite close to that mark now, with InSilico's Rentosertib in phase II trials. I am proud of our industry's ability to realize that vision from 20 years ago, and of my small part in that progress.   

The excitement of the first AI-discovered drug is wonderful, but should not be taken as evidence that AI is ready to usurp the FDA's traditional regulatory role. Even under the current very stringent regulatory scrutiny, mistakes are made that cost lives. Rofecoxib is perhaps the most obvious example, but there are of course many others.  There are many published methods to assess the safety of novel compounds for human beings, including ones based on AI.  However, none of them are perfect. The complexity and diversity of human biology means that the effects of novel compounds on …
cmcclune.bsky.social
ah, thanks for the fix!
cmcclune.bsky.social
Also crazy that the long-term-storage genome can be ~20x larger

And it’s chopped up into the just the useful pieces to form the get-shit-done genome (doi.org/10.1371/jour...)

Almost like ciliates have encrypted their genome 🤯
Reposted by Conor McClune
rebeccarhelm.bsky.social
I just learned these this elephant-trunked-shaped cells, known as ciliate, put their sexy DNA into a special pocket (called a generative nucleus), and the rest of their DNA in a normal get-shit-done nucleus.

It has functional specialization nuclei.

Respectfully: holy shit 🧵🧪
cmcclune.bsky.social
There are many total syntheses, but since Taxol is large and has a 11 chiral centers it's hard to compete with enzymes for yield/affordability…

And we were missing about half of the 22 enzymes in the pathway until this year
Reposted by Conor McClune
Reposted by Conor McClune
donmoyn.bsky.social
A friend of my compared gutting of federal agencies to a wrecking a car: if you remove 30% of the parts of the car, it does not go 30% slower. It stops working.
Reposted by Conor McClune
embojournal.org
A million shades of green: understanding and harnessing plant metabolic diversity
Rocky Payet, Anne Osbourn et al presents a step-by-step guide to starting a project that characterises plant secondary metabolites
www.embopress.org/doi/full/10....
cmcclune.bsky.social
It makes sense that skin microbes would have an intimate relationship with our immune cells.

But engineering these bugs into topical vaccines still feels like sci-fi.

Congrats @djenetbousbaine.bsky.social on the well deserved prize
djenetbousbaine.bsky.social
It’s truly an honor to receive this year’s
@science.org Noster Microbiome prize.

Here’s my essay on how we can engineer skin microbes to build topical vaccines:
science.org
🎉 Congratulations to Djenet Bousbaine, winner of the 2025 NOSTER & Science Microbiome Prize for her work to illuminate how the immune system responds to the beneficial skin microbiome.

Learn more: scim.ag/4lVwpFx